Inflection Point Acquisition Corp. III
NASDAQ:IPCXAsset Management
-$0.00 today
- Market cap
- $136.17M
- Beta
- 0.03
- P/E (TTM)
- 115.7
- EPS (TTM)
- $0.09
Volume 0.16M
Average 0.07M
IPCX Total Liabilities
Everything the company owes to creditors and other parties.
Inflection Point Acquisition Corp. IIINASDAQ: IPCX
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 2173.6% from a year ago
Total liabilities stood at $15.38M at the end of Q1 FY2026, up 2173.6% from a year earlier and up 2.4% from the prior quarter.
Context
- Total liabilities amounted to 5.8% of total assets at the end of Q1 FY2026, down 120.5 pp from a year earlier.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +2173.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 15.02M USD
- Year-over-year change
- +3783.1%
- 1-year CAGR
- +3783.1%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.02M | +3783.1% |
| FY2024 | 2024-12-31 | 386.82K | — |
Total Liabilities vs competitors
How IPCX compares with its peers on the latest reported figures
- IPCX's Mar 2026 total liabilities of $15.38M is the 5th highest of the 8 companies compared; the peer median is $94.56M.
- Its year-over-year change of +2173.6% is the 2nd highest of 6, against a peer median of +23.2%.
- Total liabilities amounts to 5.8% of total assets for IPCX, versus a peer median of 23.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Feb 2026 | $744.95M | -6.8% | +0.6% | 65.4% | |
| Mar 2026 | $638.28M | -0.1% | +2.5% | 63.7% | |
SPMCSound Point Meridian Capital Inc | Mar 2026 | $175.83M | +32.7% | — | 46.9% |
BRRProCap Financial, Inc. | Mar 2026 | $94.56M | — | — | 23.6% |
| Mar 2026 | $15.38M | +2173.6% | — | 5.8% | |
TACHTitan Acquisition Corp. | Mar 2026 | $14.27M | +1749367.7% | — | 4.9% |
TLNCTalon Capital Corp. Class A Ordinary Shares | Mar 2026 | $10.42M | — | — | 4.1% |
| Mar 2026 | $8.91M | +23.2% | — | 4.2% | |
BDCIUBTC Development Corp. Unit | — | — | — | — | — |
| Peer median (excluding IPCX) | $94.56M | +23.2% | +1.6% | 23.6% | |
Competitors are the stored peer set for IPCX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 0 | 1.13M |
| Short-term Investments | 0 | 258.96M |
| Net Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Other Current Assets | 0 | (258.78M) |
| Total Current Assets | 5.53K | 1.3M |
| Property, Plant & Equipment (Net) | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-term Investments | 0 | 0 |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 320.5K | 259.83M |
| Total Non-current Assets | 320.5K | 259.83M |
| Total Assets | 326.03K | 261.13M |
| Account Payables | 0 | 302.15K |
| Short-term Debt | 126.88K | 187 |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 14.46K | 155.64K |
| Total Current Liabilities | 386.82K | 457.97K |
| Long-term Debt | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 14.46K | 14.56M |
| Total Non-current Liabilities | 14.46K | 14.56M |
| Total Liabilities | 386.82K | 15.02M |
| Common Stock | 844 | 259.78M |
| Retained Earnings | (85.8K) | (13.67M) |
| Accumulated OCI | 0 | 0 |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | (60.8K) | 246.11M |
| Total Debt | 126.88K | 187 |
| Net Debt | 126.88K | (1.13M) |
Inflection Point Acquisition Corp. III
NASDAQ:IPCX
Intrinsic Alpha fair value
Locked
Current Price
$3.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.